PDCD1 and colon carcinoma: All three RNAseq experiments used CT26 syngeneic colon carcinoma mouse models treated with murinized rat anti-mouse programmed cell death protein-1 (PD-1) antibody (muDX400) or vehicle control with the same experimental design such as treatment duration and dose.